MiR-320a inhibition up regulated CCND1, Matrix Metallopeptidase 9 (MMP9), Bcl-2, and β-catenin that increased cell proliferation and invasion in NSCLC [100]. The gene discussed is MMP9; the disease is non-small cell lung carcinoma.